News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

December 3, 2024

Lipidor presents Nomination Committee

STOCKHOLM, Sweden, 3rd December 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today presents its Nomination Committee, which shall have four members, in accordance with the applicable instructions resolved by the Annual General Meeting 2020. The three largest shareholders who are registered with Euroclear Sweden AB on…

April 23, 2021

Lipidor’s subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova

Stockholm, Sweden, 23 April 2021 – Sweden's innovation authority Vinnova is investing in Lipidor's subsidiary Emollivet. The funding from Vinnova is for…

April 22, 2021

Lipidor – update on the company’s phase III clinical trial of drug candidate AKP02 for treatment of psoriasis

Stockholm, Sweden, 22 April 2021 – Lipidor AB (publ) (Nasdaq First North: LIPI) today provides an update on the planned Phase III…

February 23, 2021

Lipidor AB (publ) publishes year-end report for 2020

Stockholm, 23 February 2021: Today, Lipidor AB publishes its year-end report for the period 1 January – 31 December 2020. The report…

January 18, 2021

Lipidor and Cannassure enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor’s AKVANO[®] technology

STOCKHOLM, Sweden, 18 January 2021 – Lipidor AB (Nasdaq First North:LIPI) today announced that the Company has signed an exclusive licensing agreement…

December 16, 2020

Lipidor signs cooperation agreement with contract manufacturer to offer licensees the opportunity for GMP production

STOCKHOLM, Sweden, 16 December 2020 – Lipidor AB (Nasdaq First North:LIPI) announced today that the Company has signed a new cooperation agreement…

November 27, 2020

Lipidor presents Nomination Committee

Stockholm, 27 November 2020 – Lipidor’s Annual General Meeting on 11[th] June 2020, adopted an instruction regarding the appointment of the Nomination…

November 19, 2020

Lipidor publishes interim report for Q3 2020

STOCKHOLM, 19 August 2020: Today, Lipidor AB publishes its interim report for the period July – September 2020. The quarterly report is…

October 1, 2020

Lipidor strengthens management through strategic hire

Stockholm, 1 October 2020: Lipidor AB (Nasdaq First North: LIPI) today announces that the company is strengthening its management team through the…

September 30, 2020

Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company’s AKVANO® technology

Stockholm, 30 September 2020 – Lipidor AB (Nasdaq First North:LIPI) today announces a positive outcome of the feasibility study into the development…

August 18, 2020

Correction: Lipidor publishes interim report for H1 2020

In the last press release, Lipidor published that the information and interim report was such that Lipidor is required to publish under…